Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

HPV-prevalence in elderly women in Denmark

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Andersen, B, Christensen, BS, Christensen, J, Ejersbo, D, Heje, HN, Jochumsen, KM, Johansen, T, Larsen, LG, Lynge, E, Serizawa, R, Viborg, PH & Waldstrøm, M 2019, 'HPV-prevalence in elderly women in Denmark' Gynecologic Oncology, vol. 154, no. 1, pp. 118-123. https://doi.org/10.1016/j.ygyno.2019.04.680

APA

Andersen, B., Christensen, B. S., Christensen, J., Ejersbo, D., Heje, H. N., Jochumsen, K. M., ... Waldstrøm, M. (2019). HPV-prevalence in elderly women in Denmark. Gynecologic Oncology, 154(1), 118-123. https://doi.org/10.1016/j.ygyno.2019.04.680

CBE

Andersen B, Christensen BS, Christensen J, Ejersbo D, Heje HN, Jochumsen KM, Johansen T, Larsen LG, Lynge E, Serizawa R, Viborg PH, Waldstrøm M. 2019. HPV-prevalence in elderly women in Denmark. Gynecologic Oncology. 154(1):118-123. https://doi.org/10.1016/j.ygyno.2019.04.680

MLA

Vancouver

Andersen B, Christensen BS, Christensen J, Ejersbo D, Heje HN, Jochumsen KM et al. HPV-prevalence in elderly women in Denmark. Gynecologic Oncology. 2019 Jul;154(1):118-123. https://doi.org/10.1016/j.ygyno.2019.04.680

Author

Andersen, Berit ; Christensen, Birgitte Schütt ; Christensen, Jette ; Ejersbo, Dorthe ; Heje, Hanne Nørgaard ; Jochumsen, Kirsten Marie ; Johansen, Tonje ; Larsen, Lise Grupe ; Lynge, Elsebeth ; Serizawa, Reza ; Viborg, Petra Hall ; Waldstrøm, Marianne. / HPV-prevalence in elderly women in Denmark. In: Gynecologic Oncology. 2019 ; Vol. 154, No. 1. pp. 118-123.

Bibtex

@article{f2b088a0819c4d3c9f6743354c10c4fe,
title = "HPV-prevalence in elderly women in Denmark",
abstract = "AIM: In countries like Denmark, cervical cancer incidence is at present relatively high in elderly women, while routine screening stops at age 65 years. On this background, all women aged 69 and above were invited to human papillomavirus (HPV)-screening in Denmark in 2017.METHODS: Women were identified from the Central Population Register and personally invited by digital or ordinary mail to have a screening sample taken by their general practitioner. In four regions, samples were tested for high risk (HPV) with the cobas 4800{\circledR} HPV-assay, and in the last region with the BD Onclarity{\circledR} HPV-assay. Participation rate, prevalence of high risk HPV, and proportion of positive samples with HPV16, HPV18, and other high risk HPV-types were tabulated by 5-year age-groups.RESULTS: 455,612 women were invited, and 30.2{\%} (95 confidence interval (CI) 30.0-30.3) participated. Average age of participants was 74.6 years. Overall, 4.3{\%} (95{\%} CI 4.1-4.4) of participants were HPV-positive, of whom 24{\%} had HPV 16/18. HPV-prevalence decreased slightly from 4.5{\%} in women aged 69-73 years to 3.1{\%} in women aged 84-88 years, but was 5.2{\%} in the very small group of participants aged 89+ years.CONCLUSION: Invitation to HPV-screening was well received by elderly women. The HPV-prevalence decreased slightly with increasing age. No rebound of HPV-prevalence after menopause was found when our data were combined with previously published Danish data from younger women. The presently relatively high cervical cancer incidence in elderly women was not reflected in the HPV-prevalence.",
keywords = "Age, Cervical cancer, Human papillomavirus, Prevalence, Screening, Human papillomavirus 18/isolation & purification, Age Factors, Humans, Papillomavirus Infections/epidemiology, Early Detection of Cancer/statistics & numerical data, Denmark/epidemiology, Emigration and Immigration/statistics & numerical data, Human papillomavirus 16/isolation & purification, Uterine Cervical Neoplasms/diagnosis, Aged, 80 and over, Postmenopause, Female, Registries, Aged",
author = "Berit Andersen and Christensen, {Birgitte Sch{\"u}tt} and Jette Christensen and Dorthe Ejersbo and Heje, {Hanne N{\o}rgaard} and Jochumsen, {Kirsten Marie} and Tonje Johansen and Larsen, {Lise Grupe} and Elsebeth Lynge and Reza Serizawa and Viborg, {Petra Hall} and Marianne Waldstr{\o}m",
note = "Copyright {\circledC} 2019 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2019",
month = "7",
doi = "10.1016/j.ygyno.2019.04.680",
language = "English",
volume = "154",
pages = "118--123",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press",
number = "1",

}

RIS

TY - JOUR

T1 - HPV-prevalence in elderly women in Denmark

AU - Andersen, Berit

AU - Christensen, Birgitte Schütt

AU - Christensen, Jette

AU - Ejersbo, Dorthe

AU - Heje, Hanne Nørgaard

AU - Jochumsen, Kirsten Marie

AU - Johansen, Tonje

AU - Larsen, Lise Grupe

AU - Lynge, Elsebeth

AU - Serizawa, Reza

AU - Viborg, Petra Hall

AU - Waldstrøm, Marianne

N1 - Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2019/7

Y1 - 2019/7

N2 - AIM: In countries like Denmark, cervical cancer incidence is at present relatively high in elderly women, while routine screening stops at age 65 years. On this background, all women aged 69 and above were invited to human papillomavirus (HPV)-screening in Denmark in 2017.METHODS: Women were identified from the Central Population Register and personally invited by digital or ordinary mail to have a screening sample taken by their general practitioner. In four regions, samples were tested for high risk (HPV) with the cobas 4800® HPV-assay, and in the last region with the BD Onclarity® HPV-assay. Participation rate, prevalence of high risk HPV, and proportion of positive samples with HPV16, HPV18, and other high risk HPV-types were tabulated by 5-year age-groups.RESULTS: 455,612 women were invited, and 30.2% (95 confidence interval (CI) 30.0-30.3) participated. Average age of participants was 74.6 years. Overall, 4.3% (95% CI 4.1-4.4) of participants were HPV-positive, of whom 24% had HPV 16/18. HPV-prevalence decreased slightly from 4.5% in women aged 69-73 years to 3.1% in women aged 84-88 years, but was 5.2% in the very small group of participants aged 89+ years.CONCLUSION: Invitation to HPV-screening was well received by elderly women. The HPV-prevalence decreased slightly with increasing age. No rebound of HPV-prevalence after menopause was found when our data were combined with previously published Danish data from younger women. The presently relatively high cervical cancer incidence in elderly women was not reflected in the HPV-prevalence.

AB - AIM: In countries like Denmark, cervical cancer incidence is at present relatively high in elderly women, while routine screening stops at age 65 years. On this background, all women aged 69 and above were invited to human papillomavirus (HPV)-screening in Denmark in 2017.METHODS: Women were identified from the Central Population Register and personally invited by digital or ordinary mail to have a screening sample taken by their general practitioner. In four regions, samples were tested for high risk (HPV) with the cobas 4800® HPV-assay, and in the last region with the BD Onclarity® HPV-assay. Participation rate, prevalence of high risk HPV, and proportion of positive samples with HPV16, HPV18, and other high risk HPV-types were tabulated by 5-year age-groups.RESULTS: 455,612 women were invited, and 30.2% (95 confidence interval (CI) 30.0-30.3) participated. Average age of participants was 74.6 years. Overall, 4.3% (95% CI 4.1-4.4) of participants were HPV-positive, of whom 24% had HPV 16/18. HPV-prevalence decreased slightly from 4.5% in women aged 69-73 years to 3.1% in women aged 84-88 years, but was 5.2% in the very small group of participants aged 89+ years.CONCLUSION: Invitation to HPV-screening was well received by elderly women. The HPV-prevalence decreased slightly with increasing age. No rebound of HPV-prevalence after menopause was found when our data were combined with previously published Danish data from younger women. The presently relatively high cervical cancer incidence in elderly women was not reflected in the HPV-prevalence.

KW - Age

KW - Cervical cancer

KW - Human papillomavirus

KW - Prevalence

KW - Screening

KW - Human papillomavirus 18/isolation & purification

KW - Age Factors

KW - Humans

KW - Papillomavirus Infections/epidemiology

KW - Early Detection of Cancer/statistics & numerical data

KW - Denmark/epidemiology

KW - Emigration and Immigration/statistics & numerical data

KW - Human papillomavirus 16/isolation & purification

KW - Uterine Cervical Neoplasms/diagnosis

KW - Aged, 80 and over

KW - Postmenopause

KW - Female

KW - Registries

KW - Aged

UR - http://www.scopus.com/inward/record.url?scp=85065447780&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2019.04.680

DO - 10.1016/j.ygyno.2019.04.680

M3 - Journal article

VL - 154

SP - 118

EP - 123

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -

ID: 57194004